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Gastric lymphInfection of small ruminants with Teladorsagia circumcincta has, until now, been controlled using a
combination of pasture management and frequent anthelmintic treatments. Resistance to the commonly
used anthelmintics has driven research into the development of a subunit vaccine, encouraged by the
demonstration of development of protective immunity in sheep following exposure to this parasite. Local
immune effectors in the abomasum, in particular IgA, are thought to play important roles in naturally-
and experimentally-acquired immunity. L3s represent the ﬁrst contact of this pathogen with the host
immune system and, herein, the presence of L3 antigen-speciﬁc IgA was demonstrated in abomasal
mucus from immune sheep. This antibody source was used to immunoafﬁnity purify and identify
IgA-reactive molecules present in L3s. We identiﬁed 155 different proteins in this way, including a num-
ber of activation-associated secretory proteins, venom allergen-like-type proteins, detoxifying enzymes,
galectins and a suite of other potential vaccine candidate molecules. Levels of immunoafﬁnity-enriched
L3 antigen-speciﬁc IgA in gastric lymph from previously-infected sheep were statistically signiﬁcantly
higher (P = 0.004) than those measured in helminth-free sheep and a statistically signiﬁcant negative
correlation (P = 0.005, rs = 0.565) was identiﬁed between immunoafﬁnity-enriched L3 antigen-speciﬁc
IgA levels in efferent gastric lymph and total T. circumcincta burden measured at necropsy. In addition,
a statistically signiﬁcant positive correlation (P = 0.007, rs = 0.534) was measured between immunoafﬁn-
ity-enriched L3 antigen-speciﬁc IgA levels in efferent gastric lymph and the percentage of inhibited L4s
enumerated at necropsy. These results indicate that the puriﬁed antigens contain components that could
be strongly considered as vaccine candidates.
 2014 The Authors. Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
In temperate regions, Teladorsagia circumcincta is the most pre-
valent gastrointestinal nematode of small ruminants (e.g. Bartley
et al., 2003). This parasite is currently controlled using a combina-
tion of pasture management and anthelmintic treatments; how-
ever, anthelmintic resistance, including multi-class resistance, to
Class I, II and III anthelmintics is now widespread (Bartley et al.,
2003, 2004; Sargison et al., 2007). Protective immunity against T.
circumcincta can be induced after repeated exposure of sheep
through natural exposure or experimental infection (Seaton et al.,
1989; Singleton et al., 2011) and this has driven research into thedevelopment of a subunit vaccine (Nisbet et al., 2013). From exper-
imental studies, it is evident that protective responses act at vari-
ous points in the parasite’s lifecycle to decrease larval
establishment in the abomasal mucosa, slow larval development
at this site and diminish female worm fecundity (Smith et al.,
1985, 1986; Seaton et al., 1989; Stear et al., 2004a,b). Local
immune effectors in the abomasum, in particular IgA, are thought
to play important roles in immunity (Smith et al., 1985; Strain
et al., 2002) and abomasal IgA has been used as a tool to identify
potential vaccine candidates from T. circumcincta (e.g. Smith
et al., 2009). Subsequently recombinant protein versions of eight
molecules, identiﬁed primarily in L4s through a combination of
immunoproteomics, bioinformatics and functional analysis
(Redmond et al., 2006; Smith et al., 2009; Nisbet et al., 2010), were
shown to induce statistically signiﬁcant levels of immunity against
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a cocktail (Nisbet et al., 2013). In these trials, statistically signiﬁ-
cant reductions in faecal egg shedding (up to 70%) and abomasal
worm burdens (up to 75%) were observed in vaccinated compared
with adjuvant-only recipients.
To further enhance efﬁcacy of this vaccine, candidate antigen
discovery should encompass host/parasite interactions beyond
the L4 stage. L3s represent the ﬁrst contact of this pathogen with
the host immune system and immunisation of sheep with L3
surface antigens stripped from the epicuticle using detergent and
formulated with beryllium hydroxide adjuvant has been shown
to induce 72% mean reductions in worm burdens compared with
adjuvant-only recipients following challenge (Wedrychowicz
et al., 1992, 1995). In sheep rendered immune through continual
L3 infection, an immediate type hypersensitivity reaction has been
identiﬁed against incoming L3s and has been proposed as respon-
sible, in part, for preventing parasite establishment in the gastric
wall (Smith et al., 1984; Seaton et al., 1989; Stear et al., 1995).
An additional mechanism of protection which focused on L3 stages
was highlighted in subsequent experiments in which levels of L3/
early L4 excretory/secretory (ES) antigen-speciﬁc IgA in the
abomasal mucus of immune ewes were demonstrated to display
an inverse relationship with worm burden following challenge
(Smith et al., 2009). In the current study, the objective was to iden-
tify which L3 antigens might be generating protective IgA
responses in T. circumcincta-infected sheep. To do this, IgA-reactive
molecules from L3s were immunoafﬁnity puriﬁed in their native
state and then subjected to proteomics analysis. Next, local IgA lev-
els to the puriﬁed antigens were measured in a cohort of sheep and
the strength of the relationships between L3 antigen-speciﬁc IgA
and parasitological correlates of immunity were assessed to inform
their potential as vaccine candidates.
2. Materials and methods
2.1. Ovine abomasal mucus and gastric lymph
Abomasal mucus was derived from samples from a previous
study (described in Knight et al., 2011; Halliday et al., 2012).
Brieﬂy, 8 month-old Scotch Mule (Blackface ewe X Blue-faced
Leicester ram) sheep, raised under conditions designed to mini-
mise the risk of helminth exposure, were divided into two groups.
Group M-PI (mucus-previously infected) sheep were trickle
infected with 2,000 T. circumcincta L3s, administered orally, three
times per week for 8 weeks. Group M-CO (mucus-control) sheep
were maintained under helminth-free conditions. At the end of
the trickle-infection, both groups were administered fenbendazole
(5 mg kg1 orally). Seven days later, both groups were challenged
with a single bolus dose of 50,000 T. circumcincta L3s, administered
orally. All animals were euthansed 2 days later, the abomasum
removed and mucus collected from the lumenal surface (Smith
et al., 2009), and stored at 20 C until use.
Efferent gastric lymph was also used in the current study. These
latter samples had been collected following cannulation of the com-
mon gastric lymph duct of yearling Suffolk–Dorset cross or Scotch
Mule sheep (Halliday et al., 2007). The animals had been experi-
mentally infected with T. circumcincta using the protocol described
above, to provide material from two groups – GL-PI (Gastric lymph,
previously infected, n = 13) and GL-CO (Gastric lymph, control,
n = 10) (Halliday et al., 2007). Finally, efferent gastric lymph was
collected from an additional group of sheep, GL-HF, which had been
reared under conditions designed to exclude infection with hel-
minths (gastric lymph helminth-free n = 6). All studies described
herein involving sheep were performed under the regulations of a
UK Home Ofﬁce Project Licence; experimental design was ratiﬁed
by Moredun Research Institue Experiments and Ethics Committee.2.2. Determination of immunoreactivity of T. circumcincta antigen
extracts
For ELISA and immunoblot experiments, soluble extracts of T.
circumcincta L3s were prepared as described previously (Nisbet
et al., 2009). Brieﬂy, T. circumcincta L3s were harvested from copro-
culture and homogenised in ice-cold PBS using a Hybaid
RiboLyser™ with Q-Biogene lysing matrix D (4  20 s lysis at
power setting 6), followed by centrifugation at 13,000g for
10 min at 4 C. Protein concentrations were determined using the
bicinchoninic acid (BCA) protocol (Pierce, USA) with BSA standards.
For quantitative assessment of antigen-speciﬁc antibodies in
abomasal mucus and gastric lymph by ELISA, microtitre plates
(Greiner Bio-One, UK, ﬂat-bottomed, high binding) were coated
with 50 ll of 5 lg ml1 T. circumcincta extract from L3s or with
IgA-afﬁnity-puriﬁed T. circumcincta L3 extract (see Section 2.3), in
50 mM sodium bicarbonate, pH 9.6, and incubated at 4 C over-
night. Plates were washed six times with PBS containing 0.05%
(v/v) Tween-20 (PBST), then incubated with blocking buffer (10%
soya milk powder (Infasoy, Cow and Gate, UK) in PBST) for 2 h at
room temperature. After re-washing, plates were incubated with
50 ll of primary antibody (pooled abomasal mucus (derived from
four M-PI sheep or from two M-CO sheep) or individual efferent
gastric lymph samples, diluted at 1:5 and 1:20 in TNTT, (10 mM
Tris, 0.5 M NaCl, 0.05% Tween-20, 0.01% thiomersal, pH 7.4),
respectively), and incubated for 2 h at room temperature. After
washing, 50 ll of secondary antibody (mouse monoclonal anti-
bovine/ovine IgA Serotec, UK, MCA628) diluted in TNTT (1:1000)
were added and incubated for 1 h at room temperature. Following
washing, 50 ll of tertiary antibody (rabbit anti-mouse immuno-
globulins horseradish peroxidase (HRP)-conjugate, Dako, UK,
P0260) diluted 1:1000 in TNTT, were added to each well and incu-
bated for 1 h at room temperature. Plates were washed six times in
PBST and 50 ll of O-phenylenediamine dihydrochloride (OPD) sub-
strate (Sigma Fast™, Sigma–Aldrich, UK) were added. Plates were
incubated in the dark for 20 min, the reaction stopped by addition
of 25 ll of 2.5 M H2SO4 per well and the O.D. read at 492 nm on a
spectrometer. All tests were conducted in triplicate on each plate
and each plate was repeated on two independent occasions. Nega-
tive controls, omitting the primary antibody incubation step, were
included on each plate. A pool of efferent gastric lymph collected
from GL-PI sheep at the time point corresponding to the peak total
IgA concentration, 6–10 days post challenge (pc) (Halliday et al.,
2007), was used as a positive reference sample on all plates.
Two-dimensional (2-D) immunoblots of T. circumcincta L3
extracts were performed as described previously (Huntley et al.,
2004; Nisbet et al., 2009). Proteins separated by 2-D electrophore-
sis were transferred onto polyvinylidene ﬂuoride (PVDF) mem-
branes according to the manufacturer’s instructions (Invitrogen,
UK). For sodium periodate-treated 2-D blots, following electroblot-
ting, blots were incubated with 50 mM sodium acetate for 1 h at
room temperature in the dark, washed twice in TNTT and incu-
bated in 50 mM sodium borohydride/TNTT for 30 min at room
temperature, before three ﬁnal washes in TNTT prior to incubation
with the primary antibody. All antibody incubation steps were as
described previously (Nisbet et al., 2013) using primary antibody
(abomasal mucus diluted 1:5 in TNTT) with the appropriate sec-
ondary and conjugated tertiary antibody at the same dilutions used
for ELISA (see above). After application of the ﬁnal HRP-conjugated
antibody, blots were re-washed in TNTT, then incubated in
3,30-diaminobenzidine (DAB, Sigma Fast™, Sigma–Aldrich).
2.3. IgA afﬁnity puriﬁcation of L3 immunoreactive antigens
Abomasal mucus samples from four M-PI sheep were pooled
and diluted 1:3 in PBS, pH 7.4, to a ﬁnal volume of 20 ml and
Fig. 1. Antigen-speciﬁc mucus IgA responses in previously-infected and primary-
infected sheep to Teladorsagia circumcincta L3 antigens. Group M-PI represents
abomasal mucus pooled from four previously-infected sheep and group M-CO
represents abomasal mucus pooled from two helminth-naïve sheep. All animals
were given a single bolus infection of 50,000 T. circumcincta L3s and necropsied
2 days later. Group GL-HF represents pooled efferent gastric lymph from six
helminth-naïve sheep. The positive control was pooled efferent gastric lymph
collected during days 6–10 post-challenge from previously-infected/bolus-
challenged sheep. The mean OD490 values (±S.E.M.) from two sets of triplicate
wells are shown as a percentage of the positive control. Mean L3 antigen-speciﬁc
IgA levels of M-PI sheep were statistically signiﬁcantly higher (P < 0.001) than M-CO
and GL-HF sheep, respectively.
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supernatant was loaded onto a 1 ml HiTrap Protein G column (GE
Healthcare, UK) which had been pre-equilibrated with PBS. The
column was washed with 10 volumes of PBS and the unbound
material collected. Unbound protein, containing IgA depleted of
IgG, was concentrated to 1 ml at 4 C using Amicon centrifugal
Ultra-4 devices with a 10 kDa molecular weight cut-off (MWCO)
membrane, then puriﬁed by size-exclusion chromatography using
a Superose 12 HR 10/30 column (GE Healthcare) coupled to a fast
protein liquid chromatography (FPLC) apparatus (AKTA™ puriﬁer
UV-900/P-900). IgA puriﬁed in this way was bound to a HiTrap
NHS-activated HP column (GE Healthcare) following the manufac-
turer’s instructions. The IgA-NHS afﬁnity column was equilibrated
prior to immunoafﬁnity puriﬁcation by washing with 10 column
volumes of PBS at a ﬂow rate of 0.5 ml min1. L3 extracts, prepared
as described in Section 2.2, were centrifuged at 14,000g for 10 min
and 10 ml of the supernatant (7 mg of protein) were re-circulated
through the column at a ﬂow rate of 0.5 ml min1 for 16 h at 4 C.
Following sample application, unbound material was washed from
the column with 10 column volume washes of PBS at a ﬂow rate of
0.5 ml min1 and bound antigens eluted with two column volumes
of 0.1 M glycine–HCl, 6 M urea, pH 2.5. Eluted fractions (10 ml)
were pooled and concentrated to approximately 500 ll using
Amicon Ultra-15 10 kDa MWCO centrifugal devices at 3000g for
20 min at 4 C. The concentrated protein preparations were then
buffer-exchanged with PBS over three washes and the remaining
material transferred to Microcon YM-10 10 kDa MWCO centrifugal
units. The concentrator units were centrifuged at 10,000g at 4 C for
20 min, until samples were concentrated to approximately 50 ll.
2.4. Proteomic analysis of IgA afﬁnity-puriﬁed L3 antigens
For proteomic analysis, 10 ll of concentrated afﬁnity-puriﬁed T.
circumcincta L3 extracts were fractionated by SDS–PAGE under
reducing conditions using 4–12% gradient Bis–Tris gels with MES
buffer (Invitrogen). After electrophoresis, resolved proteins were
visualised with colloidal Coomassie Blue (Simply Blue Safe Stain,
Invitrogen) and destained in water. Gel tracks under investigation
were sliced horizontally into 26 equal gel slices of approximately
2.5 mm width and analysed as described in Smith et al. (2009).
The resulting chromatography data were processed and Mascot-
compatible ﬁles created using DataAnalysis™ 3.2 software (Bruker
Daltonics, UK). Mascot-compatible were ﬁles generated, inserted
into ProteinScape, version 2.1.0.577 (Bruker Daltonics) and were
searched against ﬁve databases:
(i). Nembase Version 4 (http://www.nematodes.org/nematode-
ESTs/nembase.html), July 2011 release;
(ii). A T. circumcincta expressed sequence tag (EST) database gen-
erated by suppressive subtractive hybridisation (SSH)
(Nisbet et al., 2008);
(iii). A T. circumcincta L4 database generated by next generation
sequencing using Roche-454 titanium technology of cDNA
synthesised using total RNA extracted from T. circumcincta
L4s (day 7 p.i.) as described in Nisbet et al. (2010);
(iv). A T. circumcincta L3 dataset created by 454 sequencing of
cDNA derived from RNA obtained from L3s exposed to either
an immune or naive ovine abomasal environment (Halliday
et al., 2012);
(v). A T. circumcincta adult EST database generated by next gen-
eration sequencing, using 454 GS-FLX titanium technology
of cDNA synthesised using RNA extracted from
T. circumcincta adults as described in Menon et al. (2012).
Interpretation and presentation of MS data were performed in
accordance with published guidelines (Taylor and Goodlett,2005). Fixed and variable modiﬁcations selected were carbami-
domethyl and oxidation, respectively, and mass tolerance values
set at 1.5 and 0.5 Da for MS and MS/MS, respectively. Molecular
weight search (MOWSE) scores obtained for individual protein
identiﬁcations were inspected manually and considered signiﬁcant
only if: (i) two unique peptides were matched for each protein, and
(ii) each peptide contained an unbroken ‘‘b’’ or ‘‘y’’ ion series of a
minimum of four amino acid residues. Protein identiﬁcations were
conﬁrmed further with a MOWSE score of 42 or higher indicating
that the match was statistically signiﬁcant at the 95% conﬁdence
level when searching against the four datasets. All MS analyses
were performed at the Moredun Research Institute Proteomics
Facility, UK.2.5. Statistical analysis
The data from each antigen-speciﬁc ELISA analysis using pooled
abomasal mucus (Fig. 1) were statistically evaluated by linear
mixed-effect modeling of OD490 variation between groups, with
the random effect of plate added to take account of any plate
effects from the sampled pools. Standard Tukey post hoc pairwise
comparisons were performed if any overall differences were found.
For the analysis of differences between groups in levels of binding
of IgA from efferent gastric lymph to immunoafﬁnity-puriﬁed L3
extract standard one-way ANOVA was performed on the mean
OD490/individual sheep, with equivalent standard Tukey post hoc
comparisons. Relationships between three immunological parame-
ters: (i) total IgA concentration in efferent gastric lymph at 7 days
pc, (ii) total nematode burden and (iii) percentage of inhibited L4s,
and the level of IgA binding to the IgA-afﬁnity puriﬁed antigens
were investigated by non-parametric Spearman rank correlation
coefﬁcient analyses. All statistical analyses were carried out in R
(v 3.0.0  2013 The R foundation for Statistical Computing,
http://www.r-project.org/foundation), with the package ‘nlme’ (v
3.1-109) used for the linear mixed-modeling and package ‘mult-
comp’ (v-1.2-17) used for the post hoc testing, and the level of sta-
tistical signiﬁcance was set at P < 0.05.
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3.1. Determination of immunoreactivity of T. circumcincta antigen
extracts
Teladorsagia circumcincta L3-speciﬁc IgA was detected in
abomasal mucus obtained from previously-infected sheep 2 days
after the bolus challenge (Group M-PI, Fig. 1) and levels of L3-
speciﬁc IgA in these samples were statistically signiﬁcantly higher
than those measured in abomasal mucus from sheep that had only
received a single bolus infection 2 days previously (P < 0.001,
Group M-CO, Fig. 1). Multiple IgA-reactive antigens were identiﬁed
in L3 extracts by 2-D immunoblotting (Fig. 2). Several areas of
immunoreactivity, particularly at high molecular mass (>90 kDa),
were found to be periodate-sensitive (Fig. 2), demonstrating
reactivity to glycan residues on those molecules.6
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C3.2. IgA afﬁnity puriﬁcation of L3 immunoreactive antigens and
proteomic analysis of the puriﬁed antigens
Mucosal IgA from sheep subjected to a trickle infection/bolus
challenge protocol (M-PI) was puriﬁed and used to create an
immunoafﬁnity column for selecting IgA-reactive L3 antigens.
The enriched material contained a number of polypeptides over a
broad molecular weight range with enrichment of molecules of
30, 60 and >90 kDa (Fig. 3). The immunoafﬁnity-enriched L3
extract was analysed by liquid chromatography-electrospray ioni-
sation/multi-stage mass spectrometry (LC–ESI-MS/MS). The result-
ing peptides demonstrated homology to 155 unique proteins
(Supplementary Table S1), each with peptide mass ﬁngerprints
containing two unique peptides with a consecutive sequence of
four ‘b’ or ‘y’ ions with a MOWSE score of >100. Of the total
proteins identiﬁed, 28.1% were hypothetical proteins or their
function has not yet been elucidated. The remaining proteins were
classiﬁed according to their inferred function including: develop-
mental, metabolic, transport, carbohydrate binding, cuticle synthe-
sis, detoxiﬁcation, lipid binding, heat shock, protein folding,
cytoskeletal, actin binding, proteolytic enzymes, signalling and
gut-associated (Supplementary Table S1). A selection of these
proteins is presented in Table 1.6
Fig. 2. Two-dimensional SDS–PAGE and IgA-immunoblot analysis of Teladorsagia
circumcincta L3 antigens. Teladorsagia circumcincta L3 extract was resolved by two-
dimensional gel electrophoresis and stained with colloidal Coomassie blue (A) or
transferred to polyvinylidene ﬂuoride membrane by electroblotting (B, C). Follow-
ing electroblotting, antigens were either left intact (B) or treated with sodium
periodate (C) prior to incubation with abomasal mucus, pooled from previously-
infected sheep which were given a single challenge of 50,000 T. circumcincta L3s and
necropsied 2 days later. Following incubation in puriﬁed IgA, all blots were
developed as described previously (Nisbet et al., 2009).3.3. Relationships between IgA reactivity to immunoafﬁnity-puriﬁed T.
circumcincta antigens and correlates of immunity
To determine whether immune reactivity to the immunoafﬁn-
ity-enriched antigens correlated with previously measured
parameters of immunity in different groups of sheep, immunoaf-
ﬁnity-enriched antigen-speciﬁc IgA levels were assessed. Mean
levels of immunoafﬁnity-enriched antigen-speciﬁc IgA in GL-PI
sheep were statistically signiﬁcantly higher (P = 0.004) than those
measured in sheep subjected to a single infection (GL-CO) and in
GL-HF, sheep (Fig. 4) at the same time point (P = 0.044, 7 days
pc). A statistically signiﬁcant positive correlation (P < 0.001,
rs = 0.865, Fig. 5A) was observed between immunoafﬁnity-
enriched L3 antigen-speciﬁc IgA and total IgA measured in efferent
gastric lymph collected 7 days pc. Importantly, a statistically sig-
niﬁcant negative correlation (P = 0.005, rs = 0.565) was observed
between immunoafﬁnity-enriched L3 antigen-speciﬁc IgA levels
in efferent gastric lymph and the total T. circumcincta burden mea-
sured at necropsy (Fig. 5B). Furthermore, a statistically signiﬁcant
positive correlation (P = 0.007, rs = 0.534) also was observed
between immunoafﬁnity-enriched L3 antigen-speciﬁc IgA levels
in efferent gastric lymph and the percentage of inhibited L4s enu-
merated at necropsy (Fig. 5C), the latter being generally acceptedas a measure of developing protective immunity in T. circum-
cincta-infected sheep (Smith et al., 1984).
4. Discussion
Here for the ﬁrst known time, we obtained the identity of infec-
tive T. circumcincta L3 antigens bound by IgA in abomasal mucus
and efferent gastric lymph of sheep which had been rendered
immune to this important abomasal parasite. The proﬁle of IgA
immunoreactivity detected against T. circumcincta L3 antigens
was similar to that identiﬁed previously when L3 antigens were
probed with antibody-secreting cell probes derived from abomasal
lymph node cells of sheep which had been subjected to a trickle
infection of T. circumcincta L3s weekly for 9 weeks followed by a
188
98
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17*
kDa
Fig. 3. SDS–PAGE gel demonstrating IgA-immunoafﬁnity enrichment of Teladorsa-
gia circumcincta L3 extract. A sample of T. circumcincta L3 extract (SM) was passed
through a column of immobilised IgA puriﬁed from the abomasal mucus of
previously-infected sheep which had been given a single challenge of 50,000 T.
circumcincta L3s and necropsied 2 days later. The eluted, immunoafﬁnity-enriched
fraction (E1, framed) was collected in 0.1 M glycine–HCl, 6 M urea, pH 2.4. Proteins
were stained with Simply Blue stain.
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immunoreactive proﬁle of the L3 extract, coupled with the
potential for SDS–PAGE to denature and disrupt conformational
epitopes, led us to avoid traditional 2-D electrophoresis/immuno-
blotting techniques (cf. Smith et al., 2009) and here we employed
immunoafﬁnity chromatography coupled with LC–ESI-MS/MS
analysis to identify IgA-reactive antigens in the L3 extracts. The
proteomic analysis identiﬁed a range of proteins including
antigens identiﬁed as vaccine candidates in this and other systems;
in particular, activation-associated secretory proteins (ASPs),
galectins and several enzymes involved in detoxiﬁcation processes.
ASP-like and venom allergen-like (VAL) proteins are key vaccine
candidates in a number of systems (Hawdon et al., 1996, 1999) and
are highly represented in the transcriptome and proteome of
T. circumcincta L4s (Nisbet et al., 2008, 2010). ASPs are nema-
tode-speciﬁc members of a diverse family (SCP/Tpx-1/Ag5/PR-1/
Sct, SCP/TAPS) represented in all eukaryotes (Cantacessi et al.,
2009, 2012) and are thought to be involved in worm establishment
in the host (Tawe et al., 2000). Here, several IgA afﬁnity-puriﬁed
proteins showed high homology to ASPs from the hookworm
Necator americanus (Na-ASP-2) and a C-type single domain ASP
(ASP-3) from Ostertagia ostertagi (Oo-ASP-3). Na-ASP-2 was
previously the lead candidate for the human hookworm vaccineinitiative (Bethony et al., 2005) and a randomised, placebo-
controlled double-blind vaccination trial with Na-ASP-2 indicated
that immunisation of humans with recombinant Na-ASP-2 with
alhydrogel adjuvant induced antigen-speciﬁc serum IgG titres sta-
tistically signiﬁcantly higher than controls (Bethony et al., 2008;
Diemert et al., 2012). In O. ostertagi, ASPs are also prime vaccine
candidates (Meyvis et al., 2007). The identiﬁcation of an ASP poly-
peptide dominant in T. circumcincta L3s supports the proposed role
of ASPs in nematode establishment (Hawdon et al., 1996, 1999).
Here, another member of the SCP/TAPS protein family was identi-
ﬁed; this was a cysteine-rich secretory VAL protein, which is clo-
sely related to ASPs (Mitreva et al., 2007). In Brugia malayi, VAL-1
is a target of IgG3 and IgG4 in 95% of microﬁlaraemic patients
(Murray et al., 2001). Vaccination with recombinant B. malayi
VAL-1 in jirds indicated there was a protective response with a
64% decrease in the number of parasites recovered post-challenge
in immunised jirds compared with controls (Murray et al., 2001).
Immunoreactivity of structural and muscle-derived proteins,
including paramyosin, myosin and calponin, during natural expo-
sure has been observed in other proteomic studies of other hel-
minth species (Curwen et al., 2004; Kiel et al., 2007; Bennuru
et al., 2009; Murphy et al., 2010). Paramyosin has been identiﬁed
as a vaccine candidate for a range of helminths, including B. malayi
(Li et al., 1999, 2004), Taenia solium (Vázquez-Talavera et al., 2001),
Trichinella spiralis (Yang et al., 2010; Wei et al., 2011) and Schisto-
soma japonicum (McManus et al., 2001). In T. circumcincta, Murphy
et al. (2010) also identiﬁed paramyosin in L3 extracts using proteo-
mic analysis. In those studies, immunoblotting revealed that natu-
rally infected lambs develop a speciﬁc serum IgE response to this
protein.
In the work presented here, two enzymes involved in detoxiﬁ-
cation were also identiﬁed in the IgA afﬁnity-puriﬁed extract:
extracellular superoxide dismutase and glutathione-S-transferase.
Detoxifying antioxidant enzymes scavenge free radicals produced
during oxidative stress (Sheehan et al., 2001) and could play a
key role in parasite survival. Superoxide dismutase activity is
higher in L3s than in adult stages of a number of gastrointestinal
parasitic nematode species, including T. circumcincta (Knox and
Jones, 1992; Hadas and Stankiewicz, 1998) and may be involved
in counteracting the oxidative stress associated with the mucosal
inﬂammatory response during parasite invasion (Knox and Jones,
1992).
A further protein identiﬁed in the immunoafﬁnity-puriﬁed
T. circumcincta extract was thrombospondin. In Haemonchus
contortus, thrombospondin is highly immunogenic (Kooyman
et al., 2009) and is associated with the components of the galec-
tin-containing lead vaccine candidate complex, H-gal-GP; however
its transcript was previously not detected in H. contortus L3s
(Skuce et al., 2001). Galectins were also highly represented in the
T. circumcincta immunoafﬁnity puriﬁed extract here. These lectins
have a high afﬁnity for b-galactosides and have been identiﬁed
in a number of helminths (Klion and Donelson, 1994; Greenhalgh
et al., 1999, 2000; Newlands et al., 1999), including T. circumcincta
L3s (Newton et al., 1997). The role of galectins is not fully under-
stood, but these proteins may be involved in modulating the host
immune responses by mimicking host galectins (Young and
Meeusen, 2004; Vasta, 2009).
Although a large number of proteins were identiﬁable in the
IgA-afﬁnity-puriﬁed T. circumcincta L3 extract, there were a consid-
erable number that were not assigned identities or functions. The
genome sequencing project for T. circumcincta (http://www.
sanger.ac.uk/research/projects/parasitegenomics) is not yet com-
plete and it is inevitable that sequence coverage of the selected
proteins will be improved once this genome project is complete.
Disruption of carbohydrate moieties on the T. circumcincta L3
antigens altered the IgA binding proﬁle, indicating that a
Table 1
A selection of functionally-identiﬁed, potential vaccine candidate proteins identiﬁed from the proteomic analysis of an IgA-immunoafﬁnity puriﬁed fraction of Teladorsagia
circumcincta L3s.
Protein descriptiona Organism Accession number MOWSEb No. of peptides Estimated mol. weight (kDa)
ASP-2 Necator americanus AAP41952 166.1 13 26.8
ASP-3 Ostertagi ostertagi CAO00416 100.0 2 79.1
Venom allergen-like (VAL) protein Caenorhabditis brenneri EGT59294 441.1 9 66.6
DVA-1 polyprotein allergen Dictyocaulus viviparus Q24702 122.2 2 78.1
Superoxide dismutase (extracellular) Haemonchus contortus P51547 401.1 6 66.7
Glutathione-S-transferase H. contortus AAF81283 614.7 9 64.1
Thrombospondin H. contortus AFO43121 468.2 9 171.8
Paramyosin H. contortus CBO16022 365.4 6 113.1
Myosin Caenorhabditis briggsae CAP36983 382.2 5 159.6
Calponin Caenorhabditis elegans O01542 201.5 5 43.2
Ferritin C. elegans CE20622 285.4 5 76.5
Beta-D-galactosidase Brugia malayi AAA27859 367.2 8 66.3
Fructose bisphosphate aldolase T. circumcincta CBO37380 190.5 3 57.1
Galectin 1 T. circumcincta AAD39095 533.1 9 91.4
Galectin Angiostrongylus cantonensis AEK98127 296.4 7 56.2
Transthyretin like C. brenneri EGT36246 209.5 4 56.4
Fatty acid/retinol binding protein H. contortus CDJ96356 272.8 4 49.8
Putative HEH-1, lipid binding C. elegans O17271 238.7 4 61.4
Peptidyl prolyl cis–trans isomerase O. ostertagi P52013 219.1 3 55.0
Pterin-4-alpha carbinolamine C. elegans Q9TZH6 224.7 4 35.7
Cytochrome C H. contortus ACG69807 229.4 5 39.3
Putative ES protein F7 O. ostertagi CAD20464 196.0 4 41.6
DUF148-containing, gut-associated T. circumcincta AAM45145 371.7 7 68.6
Phosphatidylethanolamine binding H. contortus O16264 247.2 3 19.2
Intermediate ﬁlament protein Ascaris suum ADY43340 52.6 2 42.5
Saponin like C. elegans NP741465 71.3 2 37.3
a All proteins were identiﬁed by searching MS data against publically-available and in-house transcriptomic databases. Coverage of the full-length protein sequence by the
assigned peptides is shown under the percentage of sequence coverage.
b The protein molecular weight search (MOWSE) score is shown. All scores are above the threshold and are signiﬁcant at the 95% conﬁdence threshold.
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Fig. 4. Levels of binding of IgA in efferent gastric lymph to IgA-immunoafﬁnity
puriﬁed Teladorsagia circumcincta L3 antigens. ELISA plates were coated with IgA-
immunoafﬁnity puriﬁed L3 extract and incubated with efferent gastric lymph from
individual sheep of different infection status: Group GL-PI, previously-infected/
bolus challenge (n = 13); Group GL-CO, single bolus infection (n = 10); and Group
GL-HF, helminth-free (n = 6). Samples from Groups GL-PI and GL-CO were from a
single time-point of 7 days post-challenge with 50,000 T. circumcincta L3s. Results
are expressed as percentages of the positive control. The positive control was
efferent gastric lymph pooled from previously-infected/challenged (GL-PI) sheep
from 6–10 days post-challenge. Samples were performed in triplicate with two
independent repetitions. Mean IgA concentrations of GL-PI sheep were statistically
signiﬁcantly higher than GL-CO (⁄⁄P = 0.004) and GL-HF (⁄P = 0.044), respectively.
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Numerous nematode antigens contain unique and immunogenic
glycans, some of which may play a role in immune evasion
(Schallig and van Leeuwen, 1996; Vervelde et al., 2003; Nyame
et al., 2004; Kooyman et al., 2007; Harrison et al., 2008; van Die
and Cummings, 2010; Van Stijn et al., 2010). The three main
strongylid nematodes of sheep, T. circumcincta, H. contortus and
Trichostrongylus colubriformis, each possess three immunodomi-
nant surface molecules, two of which are thought to lack proteins(Maass et al., 2007). One of these molecules, carbohydrate larval
antigen (CarLA), is an L3-speciﬁc surface antigen. High antibody
levels generated against CarLA in infected animals have been asso-
ciated with a reduction in larval establishment, although the mol-
ecule itself is not considered to be an effective vaccine candidate
(Harrison et al., 2003a, 2003b, 2008).
Teladorsagia circumcincta L3 and L4 antigen-speciﬁc IgA levels in
abomasal mucus have been found previously to have an inverse
relationship with the length of L4 parasites recovered from the
abomasum (Stear et al., 1999,2004a,b; Strain and Stear, 1999).
Here, statistically signiﬁcant relationships between IgA reactivity
to the puriﬁed antigens and parasitological correlates of immunity
revealed that the enriched antigens could be involved in the induc-
tion of protective responses directed at regulation of total burden
and inhibition of parasite development. This is consistent with
ﬁndings from another study where a statistically signiﬁcant posi-
tive correlation was found between levels of anti-T. circumcincta
L3 serum IgA and increased frequency of inhibited L4s (Beraldi
et al., 2008). In addition, levels of circulating serum IgA generated
against T. circumcincta L3 extracts were statistically signiﬁcant and
correlated with a reduction in the number of total adult worms
measured at necropsy (Beraldi et al., 2008). Taken together, these
ﬁndings suggest that mucus IgA directed against L3 antigens has
an important role in controlling T. circumcincta development. In
the current study, some of the antigens involved in the induction
of these responses have been identiﬁed and the next steps are to
select the most appropriate antigens from this suite of proteins,
so that they can be exploited to enhance efﬁcacy of the prototype
T. circumcincta vaccine recently demonstrated to induce
statistically signiﬁcant protection in lambs (Nisbet et al., 2013).Acknowledgements
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